H. Daniel Perez M.D.
Director,Presidio Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 37 board members in 5 different organizations across 7 different industries.|
See Board Relationships
Dr. H. Daniel Perez, M.D. serves as Chief Executive Officer and Chairman at Naia Limited. He served as an Advisor and a Venture Partner at Bay City Capital LLC. Dr. Perez served as the Chief Executive Officer and President of Presidio Pharmaceuticals Inc. Previously, he was the President and Chief Executive Officer at Berlex Biosciences, where he led research and development efforts, initiated multiple human clinical trials, and oversaw the execution of numerous collaborations, ...
1700 Owens StreetPhone: 415-655-7560
San Francisco, California 94158
Board Members Memberships*
Chief Executive Officer and Chairman
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.